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Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C  
are Effective for Detection of Diabetic Nephropathy in Childhood 
Diabetic Patients
Spot urinary albumin to creatinine ratio (ACR) measurement has been suggested as a 
surrogate to 24-hr urine collection for the assessment of microalbuminuria, and cystatin C 
(cysC) is known as an advantageous marker for renal function. The aim of this study was to 
evaluate the clinical values of spot urinary ACR and serum cysC for the assessment of 
diabetic nephropathy instead of 24-hr urine microalbumin in children and adolescents with 
diabetes. A total of 113 children and adolescents (age 12-19 yr, M:F = 47:66) with type  
1 or 2 diabetes were enrolled. We evaluated the validity of spot urine ACR and serum cysC, 
and then compared them to 24-hr urine microalbumin and creatinine clearance. Spot 
urine ACR was correlated with 24-hr urine albumin excretion (R2 = 0.828, P = 0.001) and 
creatinine clearance (R2 = 0.249, P = 0.017). The ROC curve analysis of serum cysC 
demonstrated higher diagnostic accuracy than that of serum creatinine (AUC 0.732 vs 
0.615). Both the measurements of spot urine ACR and serum cysC might better predict the 
presence of diabetic nephropathy than 24-hr urine microalbumin in childhood diabetic 
patients.
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INTRODUCTION
Diabetic nephropathy is a significant complication in diabetic 
patients, and it is becoming the most common cause of end 
stage renal disease (1). Childhood diabetic patients live long 
enough for nephropathy to develop because they develop dia-
betes early, usually before reaching adolescence. Therefore, 
preventing diabetic nephropathy or delaying the disease pro-
gression by way of early detection is very important (2, 3).
 The determination of microalbuminuria has been suggested 
as an early predictor of diabetic nephropathy. The gold standard 
for measuring urine albumin excretion is still 24-hr urine collec-
tion. However, the standard clearance technique necessitates 
timed urine collection, which is not only time-consuming but 
also subject to error. Particularly, children with diabetes tend 
to collect 24-hr urine inaccurately because they are young and 
immature. Furthermore, 24-hr urinary albumin excretion rates 
can be altered by various conditions, such as intra-individual 
variability and day-to-day variation during the evolution of al-
buminuria (4).
 Recently, the albumin to creatinine ratio (ACR), measured 
from a random urine sample, was suggested to be an effective 
surrogate to 24-hr urine collection for detecting microalbumin-
uria (5-7). ACR is convenient to perform, and is less affected by 
variation in urine concentration because it is a ratio between 
two measured substances.
 Also, serum creatinine has been widely used as a marker of 
GFR, but it is not sensitive enough to detect decreased renal 
function. Therefore, various plasma low molecular weight pro-
teins have been suggested as valuable markers of decreased 
renal function in place of serum creatinine (8). Among these 
markers, previous studies demonstrated that serum cystatin C 
(cysC) might be a superior marker for the evaluation of renal 
function than serum creatinine (9). However, the effectiveness 
of cysC for estimating GFR has not been sufficiently demon-
strated in children with diabetes.
 Therefore, the aim of this study was to investigate whether 
spot urine ACR and serum cysC are accurate and effective in 
assessing renal function instead of 24-hr urine microalbumin 
in children and adolescents with diabetes.
 
MATERIALS AND METHODS
A total of 113 children and adolescents (age 12-19 yr) with type 
1 or 2 diabetes at Childhood Diabetes Clinic of Severance Chil-
dren’s Hospital were included in this study from January 2008 
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to August 2010. Ninety-eight (41 males and 57 females) patients 
were type 1 and 15 (6 males and 9 females) were type 2. Age, 
duration of disease, mean glycated hemoglobin (HbA1c), 24-hr 
urine microalbumin, ACR in spot urine, serum Cr, serum cysC, 
high sensitivity C-reactive protein (CRP), which rises in response 
to inflammation, were checked in all patients. Creatinine clear-
ance was calculated using 24-hr urine collection. Estimated GFR 
(eGFR) was calculated with the Schwartz formula for patients 
under the age of 18 yr: eGFR (mL/min/1.73 m2) = k * Height 
(cm)/serum Cr (mg/dL) (k = 0.55 in children to 13 yr of age, 
k = 0.70 in adolescent males [the constant remains 0.55 for fe-
males]) (10) and Modification of Diet in Renal Disease (MDRD) 
formula for those of ages of 18 to 19 : eGFR = 186 * (Serum Cr) - 
1.154 * (Age) - 0.203 * (0.742 if female) (11). 
 Serum creatinine was determined by an enzymatic method 
(Kodak Ektachem 700 XR-C system, Eastman Kodak, Rochester, 
NY, USA). Serum cysC was measured by automated particle-
enhanced immunonephelometry using a BN100 nephelometer 
(Dade Behring, Marburg, Germany). 
 Data were analyzed by the SAS program (version 9.1; SAS 
Institute, Cary, NC, USA). We used the generalized linear re-
gression model and chi-squared test to verify the demographic 
trends of continuous and categorical variables over the ordinal 
variable of time, respectively. Significance was determined as 
P < 0.05. The sensitivity and specificity of serum cysC, serum 
creatinine, and creatinine clearance for the detection of reduced 
GFR were assessed by the ROC curve. 
Ethics statement
This study was approved by the Institutional Review Board of 
Yonsei University Severance Hospital (IRB number 4-2012-
0001). Written informed consent was exempted from all sub-
jects as well as their parents.
RESULTS
Baseline patient characteristics are shown in Table 1. There were 
no significant differences between the type 1 and 2 diabetes 
groups regarding mean HbA1c, serum creatinine, cysC and 
creatinine clearance. Ninety six patients (85%) had normoalbu-
minuria, 17 (15%) had microalbuminuria and no patient had 
macroalbuminuria. We compared the microalbuminuria group 
with the normoalbuminuria group (Table 2). Age, duration of 
disease, and mean HbA1c levels were significantly higher in the 
microalbuminuria group than in the normoalbuminuria group, 
suggesting that the incidence of diabetic nephropathy increases 
according to the progress of the disease and poor glycemic con-
trol. Serum creatinine level was not significantly different be-
tween the two groups, but serum cysC was significantly higher 
in the microalbuminuria group (P = 0.040). Creatinine clearance 
was significantly lower in the microalbuminuria group. High 
sensitivity CRP did not differ between the two groups. Spot urine 
ACR was positively correlated with 24-hr urine albumin excre-
tion (R2 = 0.828 and P = 0.001) (Fig. 1) and negatively correlated 
with creatinine clearance (R2 = 0.249 and P = 0.017).
 We analyzed serum creatinine, cysC and spot urine ACR be-
tween the patients with creatine clearance < 60 mL/min/1.73 
m2 (group I) and those with creatine clearance > 60 mL/min/ 
1.73 m2 (group II) (Table 3). Serum creatinine did not differ be-
tween the two groups, but spot urine ACR and serum cysC were 
significantly greater in group I.
Table 1. Baseline characteristics of patients with type 1 or 2 diabetes
Parameters Type 1 DM (n = 98) Type 2 DM (n = 15) Total (n = 113) P value 
Male/female 41/57 6/9 47/66
Age (yr) 15.7 ± 4.0 16.3 ± 3.2 15.9 ± 3.7 0.435
Duration (yr) 7.1 ± 5.1 3.8 ± 3.1 6.7 ± 4.7 0.012
HbA1c (%) 8.4 ± 2.7 7.5 ± 2.8 8.1 ± 2.7 0.129
Serum creatinine (mg/dL) 0.81 ± 0.34 0.89 ± 0.42 0.83 ± 0.37 0.384
Serum cystatin C (mg/L) 0.55 ± 0.28 0.60 ± 0.35 0.57 ± 0.30 0.205
Creatinine clearance (mL/min/1.73 m2) 80.3 ± 32.9 74.1 ± 34.2 79.1 ± 35.6 0.098
Spot urine ACR (mg/g) 24.8 ± 20.8 26.3 ± 18.3 25.2 ± 20.1 0.132
24-hr urine microalbumin (mg/day) 20.4 ± 19.4 22.1 ± 16.7 23.1 ± 18.6 0.167
hs CRP (mg/dL) 0.49 ± 0.34 0.58 ± 0.50 0.53 ± 0.44 0.089
HbA1c, Glycated hemoglobin; ACR, Albumin to creatinine ratio; hs CRP, High sensitivity C-reactive protein.
Table 2. Comparison between the normoalbuminuria and microalbuminuria groups
Parameters
NormoA 
(n = 96) 
MicroA 
(n = 17) 
P value 
Type 1/2 diabetes 83/13 15/2 
Male/female 40/56   7/10 
Age (yr) 15.7 ± 4.7 17.2 ± 3.2 0.026 
Duration (yr) 6.5 ± 3.8 9.1 ± 5.2 0.012 
HbA1c (%) 7.6 ± 2.8 8.9 ± 3.6 0.037 
Serum creatinine (mg/dL) 0.76 ± 0.21 0.92 ± 0.34 0.066 
Serum cystatin C (mg/L) 0.52 ± 0.29 0.69 ± 0.33 0.040 
Creatinine clearance (mL/min/1.73 m2) 83.7 ± 31.7 62.9 ± 36.3 0.017 
Spot urine ACR (mg/g) 14.4 ± 12.9 77.8 ± 34.3 0.001
24-hr urine microalbumin (mg/day) 7.8 ± 9.2 65.9 ± 34.9 0.001
hs CRP (mg/dL) 0.57 ± 0.48 0.62 ± 0.37 0.227
NormoA, Normoalbuminuria; MicroA, Microalbuminuria; HbA1c, Glycated hemoglo-
bin; ACR, Albumin to creatinine ratio; hs CRP, high sensitivity C-reactive protein.
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 The sensitivity and specificity of serum cysC and creatinine 
compared with creatinine clearance were estimated via ROC 
curves (Fig. 2). The area under the curves (AUC) with the cut-
off value of 60 mL/min/1.73 m2 was 0.732 for serum cysC and 
0.615 for serum creatinine. The AUC was significantly higher for 
serum cysC (P = 0.028), but not for serum creatinine (P = 0.069). 
The sensitivity and specificity of cysC were 87.3% and 66.2%, 
respectively, with the upper reference limit as the cut-off. How-
ever, serum creatinine showed 74.3% and 58.3%, respectively. 
The ROC curve analysis of serum cysC demonstrated higher 
diagnostic accuracy than that of serum creatinine. 
 
DISCUSSION
The gold standard for the assessment of diabetic nephropathy 
in children is still the quantitative analysis of microalbumin 
through 24-hr urine collection. However, many factors such as 
exercise, hypertension, hyperglycemia can influence daily uri-
nary albumin excretion (12). Day-to-day variation according to 
the volume of collected urine can hinder the diagnosis of dia-
betic nephropathy (4). Discovery of microalbuminuria through 
24-hr urine collection can also be erroneous because of im-
proper collection, which commonly happens with children and 
adolescents. Therefore, a test using timed urine collection has 
been suggested to be repeated three times to confirm microal-
buminuria, but this is very hard to apply to children. 
 Recent studies have demonstrated good correlation between 
spot urine ACR and 24-hr urinary albumin excretion (6, 13). Spot 
urine ACR was thought to be more accurate because it elimi-
nates the possibility of improper collection. The method using 
spot urine samples may ensure better compliance than timed 
urine test, especially in childhood patients. Furthermore, the 
spot urine ACR has the advantage of being less affected by urine 
volume because it is a ratio of two measured substances (14).
 Nevertheless, few studies have reported the efficacy and effec-
tiveness of spot urine ACR compared with creatinine clearance 
through 24-hr urine collection in childhood patients with dia-
betes. The present study showed that spot urine ACR was close-
ly correlated with 24-hr urine albumin excretion and creatinine 
clearance in children and adolescents with diabetes. However, 
we can not definitively support that spot urine ACR should be 
used in place of 24-hr urine collected miacroalbumin due to 
the small study population. We do, however, feel that spot urine 
ACR would be useful as a screening tool when timed urine col-
lection is diffcult to obtain in out-patient settings. 
 The use of endogenous markers to evaluate renal function is 
also important in the evaluation of diabetic nephropathy. Vari-
ous low molecular proteins, such as cysC, β2-microglobulin, 
and collagen type IV, instead of serum creatinine have been 
suggested as useful endogenous markers for evaluating renal 
function (8). Among these, previous studies have demonstrated 
that cysC might be a more sensitive indicator of GFR than serum 
creatinine, but there have been few studies on cysC as an en-
dogenous marker reflecting GFR in children with diabetic ne-
phropathy (15-17).
 In the present study, the level of serum cysC, but not serum 
Table 3. Comparison of serum parameters between the creatinine clearance < 60 
and creatinine clearance > 60 groups
Parameters
CrCl < 60  
(mL/min/1.73 m2)
CrCl > 60  
(mL/min/1.73 m2)
P value 
No. 20 93
Serum creatinine (mg/dL) 0.97 ± 0.49 0.76 ± 0.31 0.058
Serum cystatin C (mg/L) 0.68 ± 0.35 0.49 ± 0.27 0.024
Spot urine ACR (mg/g) 42.8 ± 34.9 21.8 ± 20.4 0.019
CrCl, Creatinine clearance; ACR, Albumin to creatinine ratio.
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Fig. 1. Correlation between 24-hr microalbumin (mg/24 hr) and spot urine albumin 
to creatinine ratio (ACR) (mg/g). The lower cutoff for microalbuminuria; 30 (mg/24 hr) 
in 24-hr urine microalbumin represents 36 (mg/g) in spot urine ACR.
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Fig. 2. Serum cystatin C showed better diagnostic accuracy than serum creatinine at 
the cutoff value of below 60 mL/min/1.73 m2 of creatinine clearance.
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creatinine, was significantly different between the normoalbu-
minuria group and the microalbuminuria group. Estimated GFR 
according to the Schwartz and MDRD II formulas did not demon-
strate any difference between the two groups, although creati-
nine clearance was significantly lower in the microalbuminuria 
group. It is thought that serum creatinine is unable to reflect the 
early signs of decreased renal function in childhood diabetic 
patients, while serum cysC can. However, we cannot say that 
serum cysC might be surrogate marker of diabetic nephropa-
thy, because diabetic patients have the increased possibility of 
decreased renal function due to causes other than diabetic ne-
phropathy. Nevertheless, cysC based GFR is suggested to be 
a useful method for estimating renal function (18). Recently, 
Schwartz et al. proposed an updated Schwartz formula using 
cysC (19). We can estimate that cysC based GFR may be a better 
method than creatinine based GFR on the findings in this study. 
 Our studies have some limitations in that we did not per- 
form the measurement of exogenous substances such as insu-
lin, 51Cr-EDTA, 99mTc-diethylenetriaminepentaacetic acid, iohexol 
(20) or DTPA renogram, which has been suggested as the most 
accurate method to evaluate renal function. However, DTPA 
renogram or other accurate measurements based on the mea-
surement of exogenous substances are hard to perform, espe-
cially in childhood diabetic patients. More studies with a large 
sample population are needed to confirm that spot urine ACR 
can replace 24-hr urine microalbumin in childhood diabetes.
 There was a discrepancy between eGFR and creatinine clear-
ance through 24-hr urine collection in this study. For this we 
considered two possibilities. First, the discrepancy may impli-
cate that urine collection is inaccurate. Second, the MDRD for-
mula within the normal range of creatinine might not reflect 
accurate renal function.
 Nevertheless, to the best of our knowledge, the present study 
is the first to simultaneously check both serum cysC and spot 
urine ACR in children and adolescents with diabetes, and our 
study demonstrated that spot urine ACR might be a more accu-
rate, convenient, and effective indicator for the detection of mi-
croalbuminuria instead of 24-hr urine microalbumin in diabet-
ic children. CysC based GFR may be a more accurate method 
than creatinine based GFR to evaluate renal function. 
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